NEW YORK, NY / ACCESSWIRE / March 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Inari Medical, Inc. ("Inari Medical, Inc.") (NASDAQ:NARI) concerning possible violations of federal securities laws.
On February 28, 2024, after the market close, Inari Medical announced Q4 and full-year 2023 financial results and disclosed receipt of a civil investigative demand from the US Department of Justice under the federal Anti-Kickback Statute and Civil False Claims Act over certain payments to healthcare professionals. Following this news, on February 29, 2024, shares of Inari Medical, Inc. dropped more than 7%. To obtain additional information, go to:
https://zlk.com/pslra-1/inari-medical-inc-lawsuit-submission-form?prid=72683&wire=1
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212)363-7500.
WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171
https://zlk.com/
SOURCE: Levi & Korsinsky, LLP